Back to catalog
Single Growth Hormone 1mg or 2mg Vial

Tesamorelin dosing guide

FDA-approved GHRH for HIV lipodystrophy - potent for visceral fat reduction. Tesamorelin (Egrifta) is the only FDA-approved treatment specifically for reducing visceral adipose tissue. It's a modified GHRH analog with enhanced stability and potency.

GH Release Cycle

Secretagogues trigger pulsatile growth hormone release from the pituitary.

Quickstart Highlights

  • Dosage: 1-2mg
  • Frequency: Daily
  • Administration: Subcutaneous
  • Cycle length: 12-26 weeks

Dosing Plan

Weeks Dose Units
Standard plan 2mg once daily Full vial (if 2mg) or 2 vials (if 1mg)
Conservative Start 1mg once daily for 2 weeks Assess tolerance before increasing
Maintenance 2mg daily ongoing Consistent daily dosing required

How to mix

2ml sterile water per 1mg vial

  1. Use the sterile water provided with pharmaceutical Tesamorelin (Egrifta).
  2. Inject diluent slowly into the vial.
  3. Roll gently between palms until dissolved (do not shake).
  4. Use immediately after reconstitution (within 24 hours).
  5. Inject into abdomen, rotating sites.

Syringe Math Reference

  • Pharmaceutical Egrifta: Reconstitute as directed, use entire contents
  • Research Tesamorelin: Varies by vial size
  • 2mg vial with 1mL water = 2mg/mL
  • 1mg vial with 0.5mL water = 2mg/mL

What you'll need

Tesamorelin Vials (2mg)

  • 4 weeks 28 vials
  • 8 weeks 56 vials
  • 12 weeks 84 vials

Insulin Syringes (U-100)

  • 4 weeks 30 syringes
  • 8 weeks 60 syringes
  • 12 weeks 90 syringes

Sterile Water (included with Egrifta)

  • 4 weeks Included
  • 8 weeks Included
  • 12 weeks Included

Alcohol Swabs

  • 4 weeks 1 × 100-count box
  • 8 weeks 1 × 100-count box
  • 12 weeks 2 × 100-count boxes

How This Works

Tesamorelin is a synthetic analog of GHRH with a trans-3-hexenoic acid modification that enhances stability and potency. It stimulates the pituitary to release growth hormone, which then mobilizes fat from visceral adipose tissue. The mechanism involves GH-induced lipolysis specifically targeting abdominal/visceral fat stores. It also appears to have direct effects on liver fat and potential cognitive benefits through GH/IGF-1 pathways.

Mechanism of Action

How Tesamorelin Works in Your Body

1

Peptide Administered

Enters bloodstream via subcutaneous injection

2

Pituitary Activation

Stimulates the pituitary gland to release GH

3

GH Pulse

Natural growth hormone pulse is amplified

4

Tissue Response

Muscles repair, bones strengthen, fat reduces

Receptor Binding

How peptides activate cellular receptors

  1. Approach
  2. Bind
  3. Activate

Benefits & Side Effects

Potential Benefits

  • Significant reduction in visceral/trunk fat (15-18% in trials)
  • FDA-approved with established efficacy data
  • Reduction in liver fat (hepatic steatosis)
  • Potential cognitive improvements in older adults
  • Improved body composition and waist circumference
  • Does not significantly affect subcutaneous fat or limb fat

Potential Side Effects

  • Injection site reactions (common - redness, itching)
  • Joint pain (arthralgia)
  • Peripheral edema (swelling)
  • Muscle pain (myalgia)
  • Elevated blood glucose (monitor if diabetic)
  • Carpal tunnel syndrome symptoms (rare)

How to store it

  • Lyophilized: Store refrigerated at 2–8°C.
  • Reconstituted: Use immediately or within 24 hours (refrigerated).
  • Tesamorelin is less stable than other GHRH analogs once reconstituted.
  • Protect from light and heat.

Good to know

  • Only FDA-approved medication for reducing visceral adipose tissue (VAT).
  • Originally approved for HIV-associated lipodystrophy (Egrifta).
  • Clinical trials showed 15-18% reduction in trunk fat over 26 weeks.
  • May have cognitive benefits - studies show improved cognitive function in older adults.
  • Also reduces liver fat (hepatic steatosis).
  • Expensive - pharmaceutical Egrifta costs $1,000+/month.
  • Research versions more affordable but quality varies.
  • Consistent daily use required for fat reduction benefits.

Community Insights

Summarised from 10 sources

Community discussions on Reddit about Tesamorelin highlight common practices and concerns. Users frequently discuss optimal timing for injections (morning vs. night) and whether it should be taken on an empty or full stomach, sometimes linking this to fasted cardio for synergistic effects. Dosing strategies are a recurring theme, with questions about 1mg, 2mg, and even 3mg daily cycles, and whether dosages can be split. The cost-benefit ratio is a significant point of discussion, with users questioning if the price is justified given the perceived benefits and comparing it to other peptides like Sermorelin. Side effects and an "adjustment period" are also mentioned, suggesting that some users experience initial discomfort or changes when starting Tesamorelin. Many users are interested in the duration of Tesamorelin cycles, with 8-12 week cycles being planned. The community also explores stacking Tesamorelin with other peptides like Ipamorelin and Tirzepatide to potentially enhance results. The effectiveness of different dosages is often evaluated based on personal experiences and perceived results. Overall, the discussions reflect a community actively seeking to optimize their Tesamorelin use through shared experiences and inquiries about its efficacy, cost, and integration with other peptides and routines.

Common Dosages Reported

  • 1mg daily (before bed)
  • 2mg daily (split morning and night or full dose)
  • 3mg daily

Side Effects Mentioned

  • Common sides during an "adjustment period"

Stacking Suggestions

  • Ipamorelin
  • Tirzepatide

What people are saying

'I'm planning on starting 1mg before bed daily on Monday and doing a 8-12 week cycle.'
'My subject has just started a tesamorelin cycle and started with 1mg night dosing. With there haven't been any notable changes in the first...'
'I've been running Tesamorelin and Ipamorelin together for the last two months. For the tesa I take 1mg 2xdaily'

Reviews & Discussion

Real experiences shared by the community — not medical advice.

Your rating:

Auto-moderated. Not medical advice.

Tesamorelin for Fat Loss and Body Composition

A user shared their positive experience using Tesamorelin at a dose of 2mg before bed for fat burning, noting significant results in body composition. They highlighted its effectiveness for targeting stubborn abdominal fat and recommended a cycle length of 8 to 12 weeks for optimal fat loss.

Tesamorelin for Joint Recovery and Healing

A forum member discussed using Tesamorelin primarily for joint recovery and inflammation, reporting great success at 1mg to 2mg daily. They noted that the peptide significantly helped with lingering gym-related injuries while providing a secondary benefit of lean muscle preservation.

Improved Sleep and Long-Term Requirements

An experienced member suggested that the primary benefit of a short 60-day Tesamorelin cycle is improved sleep quality. They advised that significant fat loss and lab improvements typically require a longer commitment of four months to a year, noting it is an expensive long-term investment rather than a fast-acting performance enhancer.

Persistent Injection Site Lumps and Burning

A user experienced persistent, sore lumps and a chemical burning sensation at the injection site after administering Tesamorelin subcutaneously. Despite adjusting their technique and ensuring the bacteriostatic water was at room temperature, the localized reactions and redness continued.

Effective Fat Loss and Belly Fat Reduction

A user reported great success using 2mg of Tesamorelin daily for fat loss, specifically targeting belly fat. They noted that while it is effective, it is expensive to run unless purchased in bulk and requires proper diet and training to see optimal results.

Experimental Regimen with Tesamorelin and Ipamorelin

A user with over two years of experience using growth hormone reported starting a new experimental regimen combining Tesamorelin and Ipamorelin. Their primary goal was to reach an IGF-1 serum range of 300-350 ng/ml while monitoring potential downregulation, though they noted limited long-term data on secretagogue efficacy for therapeutic IGF-1 levels.

Measurable IGF-1 Increase over Two Months

A user shared blood work results showing that two months of 2mg Tesamorelin before bed increased their IGF-1 levels from a natural baseline of 243 to 357. They noted it was effective for stimulation, though HGH eventually pushed their levels even higher.

Potent Lipolysis and Anabolic Effects

A user reported that Tesamorelin combined with Ipamorelin felt highly anabolic and effective for fat loss. While they noted significant initial weight loss was likely water, they described the lipolysis effects as 'crazy' while on a diet.

High Potency and Side Effect Sensitivity

A user found a 2mg dose of Tesamorelin to be too strong, leading to overstimulation of IGF levels. They compared the intensive side effects to their experience with HGH, which included ruined sleep and carpal tunnel syndrome, and planned to lower their dose to 1mg.

Improved Sleep with Minor Injection Reactions

A user reported that Tesamorelin improved their sleep quality. However, they noted that the peptide caused minor injection site pain (PIP) and skin reactions, emphasizing that the compound requires long-term use for results.

Tesamorelin for Belly Fat Loss

A user noted that Tesamorelin is highly effective for fat loss, specifically stating that it 'absolutely destroys belly fat' when used as part of a leaning-out protocol.

Positive Experience with Tesamorelin/Ipamorelin Blend

A user expressed high satisfaction with a Tesamorelin and Ipamorelin blend. They were impressed by the product's quality and the results achieved during their cycle.

Rapid Results with Tesamorelin Stack

A user reported seeing significant daily progress when combining Retatrutide and Tesamorelin. They emphasized that the results were obvious enough that they did not need to carefully analyze their physique to notice changes.

Comparison of Tesamorelin to other GHRH analogs

A user inquired about the comparative efficacy of Tesamorelin versus other GHRH analogs like CJC-1293 for cognitive benefits. They noted that Tesamorelin might share similar positive effects on executive function as seen in clinical studies regarding growth hormone-releasing factors.

Data Tracking and DEXA Scanning Results

A user shared their experience tracking body composition data via DEXA scans and smart scales while cycling Tesamorelin. They focused on monitoring trends in visceral fat levels to validate the peptide's metabolic impact over time.

Visceral Fat Reduction vs. Subcutaneous Fat

A user noted that while Tesamorelin did not significantly impact their visible subcutaneous abdominal fat, it was highly effective at reducing underlying visceral fat. They emphasized the importance of managing expectations regarding aesthetic versus internal health benefits.

Effectiveness on Visceral Fat Stores

One individual reported that Tesamorelin worked exceptionally well for targeting visceral fat specifically. They stated that the results were significant enough to be noticeable in their health markers and internal measurements, even if external fat remained.

Tesamorelin for Joint Support Inquiry

A forum member inquired about the efficacy and protocols for using Tesamorelin specifically to aid in joint recovery and relief. Other users responded that while it is primarily used for fat loss, the growth hormone-releasing effects could potentially provide secondary benefits for joint health.

Tesamorelin for Fat Loss and Body Composition

A user shared their positive experience using Tesamorelin at a dosage of 1mg to 2mg per day for a duration of 12 weeks. They reported that the peptide was highly effective for reducing stubborn belly fat and improving overall body composition.

Effective Fat Loss and Belly Fat Reduction

A user reported using 2mg of Tesamorelin daily with great success, noting that it enhances fat loss, specifically targeting visceral belly fat. They emphasized that while effective, the peptide is expensive to run at that dosage without buying in bulk.

Localized Injection Site Reactions and Lumps

A user experienced persistent, sore lumps and a chemical burning sensation at the injection site after administering Tesamorelin sub-q. Despite adjusting the volume of bacteriostatic water and injection technique, the localized reactions and redness continued to occur.

Long-term Commitment for Results

A forum member stated that Tesamorelin provides better sleep in the short term, but physical body composition changes generally require four months to a year of consistent use. They advised that the peptide is not like typical PEDs and requires a long-term commitment and significant financial investment to see results.

Tesamorelin and Ipamorelin Combination Experiment

A user on TRT reported plans to combine Tesamorelin with Ipamorelin after being on growth hormone for over two years. They expressed some concern regarding potential down-regulation and the loss of the peptide's ability to maintain high therapeutic IGF-1 levels (target 300-350 ng/ml) over time.

Clinical Summary of Tesamorelin Efficacy

In clinical contexts discussed on the forum, Tesamorelin is noted for effectively decreasing visceral adipose tissue, trunk fat, and liver fat in patients with HIV-associated lipodystrophy. Clinical data also suggests it helps increase lean body mass.

Strong Anabolic and Lipolytic Effects

A user described Tesamorelin as highly anabolic, noting that they experienced significant lipolysis while on a cycle of Tesamorelin and Ipamorelin. Despite being on a diet for only two weeks, they reported a rapid loss of 10kg, which they attributed mostly to water loss and enhanced fat burning.

Potency and Impact on Sleep Quality

A user reported that a 2mg dose of Tesamorelin was overly potent, causing side effects similar to those they experienced with HGH. They noted that high IGF levels from these substances ruined their sleep and suggested starting with a lower dose of 1mg to improve quality of life.

Improved Sleep and Minor Site Reactions

A user shared that their experience with Tesamorelin included improved sleep quality, though they noted minor injection site pain and reactions. They emphasized that the peptide requires long-term use to see significant results, particularly for goals like reducing visceral fat.

Measurable Increase in IGF-1 Levels

Using 2mg of Tesamorelin before bed for two months, a user observed their IGF-1 levels increase from a natural baseline of 243 to 357. They noted that while it was effective at stimulating GH production, they eventually moved to HGH for higher levels.

Tesamorelin for Belly Fat Loss

A user reported that Tesamorelin is highly effective for fat loss, stating that it "absolutely destroys belly fat" when used as part of a regimen to lean out.

Rapid Results with Tesamorelin Stack

A user shared that combining Retatrutide and Tesamorelin led to significant, daily visible changes in their physique. They noted that the results were obvious enough that they did not need to study their body or use specific lighting to see progress.

Tesamorelin/Ipamorelin Blend Experience

A user expressed high satisfaction with a Tesamorelin and Ipamorelin blend, noting they were impressed with both the product's performance and the professional packaging.

Inquiry on Tesamorelin vs other GHRH analogs

A user inquired about the comparative efficacy of Tesamorelin versus other GHRH analogs like CJC-1293 for cognitive benefits. They noted the potential for Tesamorelin to provide similar effects to those found in clinical studies regarding growth hormone-releasing factors.

Tracking Results via DEXA and Data Trends

One individual shared that they used the peptide to target stubborn stomach fat after long-term weight maintenance. They utilized DEXA scans to track data trends and found positive results specifically in visceral fat reduction markers.

Reduction in Visceral Fat vs. Subcutaneous Fat

A user reported that while the peptide did not significantly impact their visible subcutaneous abdominal fat, it was highly effective at reducing underlying visceral fat. They noted that the results were specific to internal fat composition rather than external aesthetics.

Auto-moderated. Not medical advice.

No discussion yet — be the first.

Auto-moderated. Not medical advice.

No notes yet — be the first.